News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
747,892 Results
Type
Article (50489)
Company Profile (285)
Press Release (697105)
Multimedia
Podcasts (83)
Webinars (15)
Section
Business (212595)
Career Advice (2106)
Deals (36592)
Drug Delivery (108)
Drug Development (83824)
Employer Resources (173)
FDA (17105)
Job Trends (15770)
News (359996)
Policy (34844)
Tag
Academia (2786)
Accelerated approval (14)
Adcomms (28)
Allergies (111)
Alliances (51758)
ALS (131)
Alzheimer's disease (1582)
Antibody-drug conjugate (ADC) (174)
Approvals (17151)
Artificial intelligence (382)
Autoimmune disease (41)
Automation (23)
Bankruptcy (374)
Best Places to Work (12095)
BIOSECURE Act (19)
Biosimilars (137)
Biotechnology (190)
Bladder cancer (113)
Brain cancer (42)
Breast cancer (424)
Cancer (3381)
Cardiovascular disease (286)
Career advice (1774)
Career pathing (33)
CAR-T (210)
CDC (43)
Cell therapy (559)
Cervical cancer (29)
Clinical research (69445)
Collaboration (1222)
Company closure (4)
Compensation (845)
Complete response letters (39)
COVID-19 (2788)
CRISPR (69)
C-suite (493)
Cystic fibrosis (121)
Data (3779)
Decentralized trials (2)
Denatured (32)
Depression (90)
Diabetes (404)
Diagnostics (6710)
Digital health (28)
Diversity (11)
Diversity, equity & inclusion (46)
Drug discovery (165)
Drug pricing (146)
Drug shortages (31)
Duchenne muscular dystrophy (173)
Earnings (90718)
Editorial (48)
Employer branding (21)
Employer resources (149)
Events (119748)
Executive appointments (916)
FDA (19311)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1079)
Gene editing (152)
Generative AI (31)
Gene therapy (442)
GLP-1 (901)
Government (4857)
Grass and pollen (5)
Guidances (332)
Healthcare (19940)
HIV (44)
Huntington's disease (32)
IgA nephropathy (47)
Immunology and inflammation (192)
Immuno-oncology (14)
Indications (47)
Infectious disease (2993)
Inflammatory bowel disease (168)
Inflation Reduction Act (10)
Influenza (82)
Intellectual property (162)
Interviews (322)
IPO (16972)
IRA (49)
Job creations (4054)
Job search strategy (1503)
Kidney cancer (13)
Labor market (64)
Layoffs (542)
Leadership (23)
Legal (8492)
Liver cancer (87)
Longevity (12)
Lung cancer (490)
Lymphoma (244)
Machine learning (22)
Management (58)
Manufacturing (524)
MASH (115)
Medical device (14577)
Medtech (14594)
Mergers & acquisitions (20434)
Metabolic disorders (1004)
Multiple sclerosis (115)
NASH (16)
Neurodegenerative disease (167)
Neuropsychiatric disorders (41)
Neuroscience (2435)
NextGen: Class of 2025 (6916)
Non-profit (4753)
Now hiring (53)
Obesity (492)
Opinion (244)
Ovarian cancer (112)
Pain (144)
Pancreatic cancer (144)
Parkinson's disease (206)
Partnered (24)
Patents (369)
Patient recruitment (265)
Peanut (54)
People (60908)
Pharmaceutical (67)
Pharmacy benefit managers (22)
Phase I (21585)
Phase II (30518)
Phase III (22775)
Pipeline (2428)
Policy (238)
Postmarket research (2742)
Preclinical (9237)
Press Release (67)
Prostate cancer (169)
Psychedelics (41)
Radiopharmaceuticals (265)
Rare diseases (544)
Real estate (6324)
Recruiting (66)
Regulatory (24590)
Reports (51)
Research institute (2498)
Resumes & cover letters (360)
Rett syndrome (11)
RNA editing (11)
RSV (58)
Schizophrenia (115)
Series A (175)
Series B (135)
Service/supplier (13)
Sickle cell disease (72)
Special edition (20)
Spinal muscular atrophy (153)
Sponsored (36)
Startups (3850)
State (2)
Stomach cancer (15)
Supply chain (90)
Tariffs (75)
The Weekly (49)
Vaccines (913)
Venture capital (60)
Weight loss (325)
Women's health (54)
Worklife (17)
Date
Today (4)
Last 7 days (493)
Last 30 days (2188)
Last 365 days (31495)
2025 (22301)
2024 (36107)
2023 (41147)
2022 (52385)
2021 (57102)
2020 (55913)
2019 (48797)
2018 (36943)
2017 (33747)
2016 (33565)
2015 (39611)
2014 (33324)
2013 (28559)
2012 (30849)
2011 (31552)
2010 (29926)
Location
Africa (801)
Alabama (71)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (41673)
Australia (6849)
California (8664)
Canada (2673)
China (810)
Colorado (371)
Connecticut (388)
Delaware (233)
Europe (90496)
Florida (1290)
Georgia (296)
Hawaii (2)
Idaho (64)
Illinois (729)
India (41)
Indiana (412)
Iowa (17)
Japan (265)
Kansas (119)
Kentucky (32)
Louisiana (17)
Maine (65)
Maryland (1185)
Massachusetts (6399)
Michigan (275)
Minnesota (525)
Mississippi (4)
Missouri (103)
Montana (28)
Nebraska (25)
Nevada (101)
New Hampshire (74)
New Jersey (2384)
New Mexico (29)
New York (2361)
North Carolina (1271)
North Dakota (8)
Northern California (3922)
Ohio (263)
Oklahoma (17)
Oregon (36)
Pennsylvania (1823)
Puerto Rico (17)
Rhode Island (43)
South America (1188)
South Carolina (45)
South Dakota (1)
Southern California (3327)
Tennessee (141)
Texas (1342)
United States (31861)
Utah (258)
Virginia (216)
Washington D.C. (78)
Washington State (737)
West Virginia (4)
Wisconsin (77)
747,892 Results for "apex medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
New data for Kodiak’s KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)
September 15, 2025
·
11 min read
Press Releases
Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation
March 17, 2025
·
4 min read
Press Releases
Apogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress
September 11, 2025
·
6 min read
Press Releases
64x Bio Launches AAV Apex Suite to Power the Next Generation of Gene Therapy Manufacturing
June 16, 2025
·
2 min read
Press Releases
Mirion to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard Software
April 2, 2025
·
3 min read
Apex Labs files IND with FDA for microdose psilocybin study
Apex Labs Ltd. (APEX or the Company) is pleased to announce the filing of an IND application with the U.S. Food and Drug Administration (FDA) for APEX-002-B01-02, a pioneering pharmacokinetics and driving simulator study of APEX-52 take home microdose psilocybin.
June 20, 2024
·
4 min read
Press Releases
Apogee Therapeutics to Host Conference Call to Report Part A 16-Week Data from the Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis on July 7, 2025
July 7, 2025
·
1 min read
Press Releases
Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis
July 8, 2025
·
10 min read
Press Releases
AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
January 13, 2025
·
8 min read
Policy
Apex Labs Granted Dealer’s Licence by Health Canada
Apex Labs Ltd., a pharmaceutical company transforming the standard of mental health care with psilocybin is pleased to announce the approval by Health Canada of APEX’s Controlled Drugs and Substances Dealer’s Licence.
February 14, 2024
·
4 min read
1 of 74,790
Next
